We are live on ! Find out more
CALA

Calithera Biosciences, Inc

Delisted

CALA was delisted on the 1st of February, 2023.

34 hedge funds and large institutions have $188M invested in Calithera Biosciences, Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$61K +$39.4K +151 New
SO
27
STRS Ohio
Ohio
$57K +$36.6K +140 New
Bank of America
28
Bank of America
North Carolina
$50K +$32.4K +124 New
UBS Group
29
UBS Group
Switzerland
$34K +$21.7K +83 New
Citigroup
30
Citigroup
New York
$30K +$19.3K +74 New
Wells Fargo
31
Wells Fargo
California
$22K +$14.4K +55 New
Morgan Stanley
32
Morgan Stanley
New York
$14K +$9.4K +36 New
Barclays
33
Barclays
United Kingdom
$13K +$8.62K +33 New
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$42 +$27.4K +105 New

CALA Hedge Fund Activity: Q4 2014 in Review

34 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2014, worth a combined $188M.

Buyers outnumbered sellers: 34 funds opened new CALA positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $36.1M.

  • 34 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $188M of Calithera Biosciences, Inc stock for Q4 2014.
  • 34 funds opened new Calithera Biosciences, Inc positions in Q4 2014 and 0 closed out, a net change of +34 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2014 was Adage Capital Partners, an estimated $36.1M added.

Based on aggregated 13F filings for Q4 2014.